Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Sharp joins the Science Based Targets initiative (SBTi) to set greenhouse gas emissions reduction targets

    Jan 24, 2024, 08:46 AM by
    Full story
  • Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future

    Jan 24, 2024, 08:46 AM by
    Leading biometrics CRO Phastar to share vast statistical expertise with biotechs working to build the drugs of the future London, UK and Durham, NC – January 23rd, 2024: Phastar, a global specialist biometrics contract research organization (CRO), has announced the launch of Stats Helpdesk, a new initiative designed to provide biotech companies with free access to its team of expert statisticians.
    Full story
  • ‘Opioid Of The Masses’ Used To Make Therapies For Neurodegenerative Diseases

    Jan 24, 2024, 01:00 AM by User Not Found
    Bio-IT World | Taking a cue from Mother Nature, researchers from The University of Texas at El Paso are exploring the use of carbon nanoparticles synthesized from caffeic acid found in coffee grounds as a preventative or therapeutic agent for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Their work marks the first time caffeic acid has been used to create carbon quantum dots and the approach is not only economical and sustainable but also potentially interventional.
    Full story
  • Evoke unveils simplified brand and structure

    Jan 23, 2024, 08:18 AM by
    Inizio Evoke delivers more connected solutions for clients to address demands of dynamic global healthcare marketplace
    Full story
  • Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness

    Jan 23, 2024, 08:18 AM by
    Creative Diagnostics has announced new Minimum Doubling Time (MDT) services to measure the effectiveness of antibacterial compounds.
    Full story
  • Rdcthera Announces RDC Development and Analysis Services Based on Its Technology Platform

    Jan 23, 2024, 08:18 AM by
    Full story
  • STEMart Launches New Force Degradation Services to Ensure Drug Stability and Safety

    Jan 23, 2024, 08:18 AM by
    STEMart announced the launch of its new Force Degradation Services.
    Full story
  • Telomere Length Aging Clocks Help to See the Unseen in Aging

    Jan 23, 2024, 08:18 AM by
    Full story
  • HighRun DataScience Propels Retail Businesses With Advanced Data Analytics

    Jan 23, 2024, 08:18 AM by
    HighRun DataScience announced statistical and data science services to empower retail businesses.
    Full story
  • CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism

    Jan 23, 2024, 08:18 AM by
    CD BioSciences has announced new services to study mTOR.
    Full story
  • Protein Signatures Of Organ Aging Could Aid Disease Prevention Efforts

    Jan 23, 2024, 01:00 AM by User Not Found
    Bio-IT World | Stanford Medicine investigators are leading the development of a test measuring organ-specific proteins in the blood as a simple and sensible way to estimate biological age. Among the potential applications are screening people for conditions such as heart failure and Alzheimer’s disease, personalizing the intervention they’re prescribed, and signaling sooner the efficacy of investigational drugs based on how well they rejuvenate certain organs.
    Full story
  • Creative Biostructure Expands Liposome Offerings for Nucleic Acid Delivery

    Jan 22, 2024, 08:54 AM by
    Full story
  • CD BioGlyco Introduces New Polysaccharide Analysis Service to Accelerate Glycobiology Research

    Jan 22, 2024, 08:54 AM by
    Full story
  • PGA Identifies Effective Drugs for Non-responder Cancer Patients

    Jan 22, 2024, 08:54 AM by
    A breakthrough technology PGA brings gene-to-drug revolution in life.
    Full story
  • To Fight Superbugs, Ace Infectious Unveils Phage Therapy Development Services

    Jan 19, 2024, 09:05 AM by
    Full story
  • AES Clean Technology expands senior leadership team with key appointment

    Jan 19, 2024, 09:05 AM by
    Montgomeryville, Pennsylvania, January 18, 2024: A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO).
    Full story
  • Inceptua Group and Cycle Pharmaceuticals Partner for a Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU)

    Jan 19, 2024, 09:05 AM by
    Inceptua Group and Cycle Pharmaceuticals Ltd have announced a partnership to make NITYR® Tablets available via a Free Goods Programme for eligible patients with Hereditary Tyrosinemia Type 1 and Alkaptonuria.
    Full story
  • Microbialtec: Your One-Stop Solution for Bacillus Genome Editing Needs

    Jan 19, 2024, 09:05 AM by
    Full story
  • 1upHealth Commits to Supporting Health Plan Compliance with Latest CMS Interoperability Rule

    Jan 19, 2024, 09:05 AM by
    Full story
  • Creative Biogene Offers High-Quality Biological Fermentation Services to Cater Research and Industrial Needs

    Jan 19, 2024, 09:05 AM by
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66 (current)
  • 67
  • 68
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy